Medtronic CoreValve® System Results Superior to Open-Heart Surgery at One Year in U.S. Pivotal Trial

[Thomson Reuters ONE] – CoreValve High Risk Study: FDA Determines Expert Panel Not Required Low Mortality Rate Exceeds Expectations for Primary Endpoint CoreValve System is First and Only Transcatheter Aortic Valve to Show Results … more

View todays social media effects on MDT

View the latest stocks trending across Twitter. Click to view dashboard

See who Medtronic is hiring next, click here to view